Abstract
Ovarian neoplasms are notoriously heterogeneous-the World Health Organization classification (1) includes 46 different epithelial tumor types, 24 sex cord stromal types, 29 germ cell types, and 13 other categories, not including 17 other tumor-like conditions (Table 1). Many of these lesions are very rare, but there is tremendous variation in the biological behavior of different tumor types, and it is very important that histopathological assessment is performed accurately. This is not only crucial to the patient, whose treatment depends on it, but also in investigative work on ovarian cancer. Uniform terminology must be used to allow comparisons between different studies and any research that involves analysis of the biological or clinical features of ovarian tumors must include expert histopathological review of cases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Scully, R. E., Fox, H., Russell, P., et al. International Histological Classification of Ovaria Tumors. Springer Verlag, Berlin, Germany (in press).
Yancik, R. (1993) Ovarian cancer:age contrasts in incidence, histology, disease stage at diagnosis, and mortality. Cancer 71, 517ā523.
Auersperg, N., Maines-Bandiera, S. L., and Kruk, P. A. (1995) Human ovarian surface epithelium: growth patterns and differentiation, in Ovarian Cancer 3, (Sharp, F., Mason, P., Blackett, T., and Berek, J., eds.), Chapman & Hall Medical, London, U.K., pp. 157ā170.
Salazar, H., Godwin, A. K., Getts, L. A., Testa, J. R., Daly, M., Rosenblum, N., et al. Spontaneous transformation of the ovarian surface epithelium and the biology of ovarian cancer, in Ovarian Cancer 3 (Sharp, F., Mason, P., Blackett, T., and Berek, J., eds.), Chapman & Hall Medical, London, U.K., pp. 145ā156.
Auersperg, N., Maines-Bandiera, S. L., Dyck, H. G., and Kruk, P. A. (1994) Characterisation of cultured human ovarian surface epithelial cells: phenotypic plasticity and premalignant changes. Lab. Invest. 71, 510ā518.
Tsao, S. W., Mok, S. C., Fey, E. G., Fletcher, J. A., Wan, T. S., Chew, E. C., et al. Characterisation of human ovarian surface epithelial cells immortalised by human papilloma virus oncogenes (HPV-E6E7 ORFs). Exp. Cell Res. 218, 499ā507.
Kruk, P. A., Uitto, V. J., Firth, J. D., Dedhar, S., and Auersperg, N. (1994) Reciprocal interactions between human ovarian surface epithelial cells and adjacent extracellular matrix. Exp. Cell Res. 215, 97ā108.
Kruk, P. A. and Auersperg, N. (1992) Human ovarian surface epithelial cells are capable of physically restructuring extracellular matrix. Amer. J. Obstet. Gynecol. 167, 1437ā1443.
Berchuck, A., Rodriguez, G. C., Kamel, A., Dodge, R. K., Soper, J. T., Clarke-Pearson, D. L., and Bast, R. C. (1991) Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer. Amer. J Obstet. Gynecol. 164, 669ā674.
Wang, D. P., Konishi, I., Koshiyama, M., Nanbu, Y., Iwai, T., Nonogaki, H., et al. (1992) Immuno-histochemical localisation of c-erb-B2 protein and epidermal growth factor receptor in normal surface epithelium, surface inclusion cysts, and common epithelial tumors of the ovary. Virchows Archiv. A 421, 393ā400.
Berchuck, A., Rodriguez, G., Olt, G., Whitaker, R., Boente, M. P., Arrick, B. A., et al. (1992) Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor beta. Amer. J. Obstet. Gynecol. 166, 676ā684.
Havrilesky, L. J., Hurteau, J. A., Whitaker, R. S., Elbendary, A., Wu, S., Rodriguez, G. C., et al. (1995) Regulation of apoptosis in normal and malignant ovarian epithelial cells by transforming growth factor beta. Cancer Res. 55, 944ā948.
Jindal, S. K., Snoey, D. M., Lobb, D. K., and Dorrington, J. H. (1994) Transforming growth factor alpha localisation and role in surface epithelium of normal human ovaries and in ovarian carcinoma cells. Gynecol. Oncol. 53, 17ā23.
Boente, M. P., Berchuck, A., Rodriguez, G. C., Davidoff, A., Whitaker, R., Xu, F. J., et al. (1992) The effect of interferon gamma on epidermal growth factor receptor expression in normal and malignant ovarian epithelial cells. Amer. J. Obstet. Gynecol. 167, 1877ā1882.
Lidor, Y. J., Xu, F. J., Martinez-Maza, O., Olt, G. J., Marks, J. R., Berchuck, A., et al. (1993) Constitutive production of macrophage colony-stimulating factor and interleukin-6 by human ovarian surface epithelial cells. Exp. Cell Res. 207, 332ā339.
Pejovic, T. (1995) Genetic changes in ovarian cancer. Ann. Med. 27, 73ā78.
Muto, M. G., Welch, W. R., Mok, S. C., Bandera, C. A., Fishbaugh, P. M., Tsao, S. W., et al. (1995). Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum. Cancer Res. 55, 490ā492.
Buller, R. E. Skilling, J. S., Sood, A. K., Plaxe, S., Baergen, R. N., and Lager, D. J. (1998) Field cancer-ization: why late ārecurrentā ovarian cancer is not recurrent. Amer. J. Obstet. Gynecol. 178, 641ā649.
Provencher, D. M., Lounis, H., Fink, D., Drouin, P., and Mes-Masson, A. M. (1997) Discordance in p53 mutations when comparing ascites and solid tumors from patients with serous ovarian cancer. Tumor Biol. 18, 167ā174.
Brescia, R. J., Barakat, R. A., Beller, U., Frederickson, G., Suhrland, M. J., et al. (1990) The prognostic significance of nuclear DNA content in malignant epithelial tumors of the ovary. Cancer 65, 141ā147.
Friedlander, M. L., Hedley, D. H., Taylor, I., Russell, P., and Tattersall, M. H. N. (1984) Influence of cellular DNA content on survival in advanced ovarian cancer. Cancer Res. 44, 397ā400.
Kaern, J., Trope, C. G., Abeler, V., and Petterson, E. O. (1995) Cellular DNA content: the most important prognostic factor in patients with borderline tumors of the ovary. Can it prevent overtreatment? in Ovarian Cancer 3 (Sharp, F., Mason, P., Blackett, T., and Berek, J., eds.), Chapman and Hall, London, U.K., pp. 181ā188.
Foulkes, W. D. and Trowsdale, J. (1995) Isolating tumor suppressor genes relevant to ovarian carcinoma-the role of loss of heterozygosity, in Ovarian Cancer 3 (Sharp, F., Mason, P., Blackett, T., and Berek, J., eds.), Chapman and Hall, London, U.K., pp. 23ā38.
Sato, T., Saito, H., Morita, R., Koi, S., Lee, J. H., and Nakamura, Y. (1991) Allelotype of human ovarian cancer. Cancer Res. 51, 5118ā5122.
Yang-Feng, T. L., Han, H., Chen, K-C., Li, S., Claus, E., Carcangui, M. L., et al. (1993) Allelic loss in ovarian cancer. Int. J. Cancer 54, 546ā551.
Steel, C. M., Cohen, B. B., Lessels, A., Williams, A. R. W., and Gabra, H. (1997). Other gene aberrations in ovarian cancer, in Ovarian Cancer 4, (Sharp, F., Mason, P., Blackett, T., and Berek, J., eds.), Chapman and Hall, London, U.K.
Obata, K., Morland, S. J. Watson, R. H., Hitchcock, A., Chenevix-Trench, G., Thomas, E. J., et al. (1998) Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Res. 58, 2095ā2097.
Skilling, J. S., Sood, A., Niemann, T., Lager, D. J., and Buller, R. E. (1996) An abundance of p53 null mutations in ovarian carcinoma. Oncogene 13, 117ā123.
Kounelis, S., Jones, M. W., Papadaki, H., Bakker, A., Swalsky, P., and Finkelstein, S. D. (1998) Carcinosarcomas (malignant mixed mullerian tumors) of the female genital tract: comparative molecular analysis of epithelial and mesenchymal components. Human Pathol. 29, 82ā87.
Abeln, E. C., Smit, V. T., Wessels, J. W., de Leeuw, W. J., Cornelisse, C. J., and Fleuren, G. J. (1997) Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed mĆ¼llerian tumors. J. Pathol. 183, 424ā431.
Skomedal, H., Kristensen, G. B., Abeler, V. M., Borresen-Dale, A. L., Trope, C., and Holm, R. (1997) TP53 protein accumulation and gene mutation in relation to overexpression of MDM2 protein in ovarian borderline tumors and stage I carcinomas. J. Pathol. 181, 158ā165.
Zheng, J., Benedict, W. F., Xu, S. X., Kim, T. M., Velicescu, M., Wan, M., et al. (1995) Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas. J. Nat. Cancer Inst. 87, 1146ā1153.
Lukas, J., Groshen, S., Saffari, B., Niu, N., Reles, A., Wen, W. H., et al. (1997) WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium. Amer. J. Pathol. 150, 167ā175.
Werness, B. A., Jobe, J. S., DiCioccio, R. A., and Piver, M. S. (1997) Expression of the p53 induced tumor suppressor p21waf1/cip1 in ovarian carcinomas: correlation with p53 and Ki-67 immunohis-tochemistry. Int. J. Gynecol. Pathol. 16, 149ā155.
Milner, B. J., Hosking, L., Sun, S., Haites, N. E., and Foulkes, W. D. (1996) Polymorphisms in p21CIP1/WAF1 are not correlated with Tp53 status in sporadic ovarian tumors. Eur. J. Cancer 32A, 2360ā2363.
Shih, Y. C., Kerr, J., Hurst, T. G., Khoo, S. K., Ward, B. G., and Chevenix-Trench, G. (1998) No evidence for microsatellite instability from allelotype analysis of benign and low malignant potential ovarian neoplasms. Gynecol. Oncol. 69, 210ā213.
Holt, J. T. (1997) Breast cancer genes: therapeutic strategies. Ann. New York Acad. Sci. 833, 34ā41.
Rubin, S. C., Benjamin, I., Behbakht, K., Takahashi, H., Morgan, M. A., LiVolsi, V. A., et al. (1996) Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. New England J. Med. 335, 1413ā1416.
Tangir, J., Muto, M. G., Berkowitz, R. S., Welch, W. R., Bell, D. A., and Mok, S. C. (1996) A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer. Oncogene 12, 735ā740.
Scully, R. E., Bell, D. A., and Abu-Jawdeh, G. M. (1995) Update on early ovarian cancer and cancer developing in benign ovarian tumors, in Ovarian Cancer 3 (Sharp, F., Mason, P., Blackett, T., and Berek, J., eds.), Chapman & Hall Medical, London, U.K., pp. 139ā144.
Bell, D. A. and Scully, R. E. (1994) Early de novo ovarian carcinoma: a study of 14 cases. Cancer 73, 1859ā1864.
Park, T. W., Felix, J. C., and Wright, T. C. (1995) X chromosome inactivation and micros atellite instability in early and advanced bilateral ovarian carcinomas. Cancer Res. 55, 4793ā4796.
Hutson, R., Ramsdale, J., and Wells, M. (1995) P53 protein expression in putative precursor lesions of epithelial ovarian cancer. Histopathol. 27, 367ā371.
La Grenade, A. and Silverberg, S. G. (1988) Ovarian tumors associated with atypical endometriosis. Human Pathol. 19, 1080ā1084.
Sainz de la Cuesta, R., Eichhorn, J. H., Rice, L. W., Fuller, A. F., Nikrui, N., and Goff, B. A. (1996) Histologic transformation of benign endometriosis to early epithelial ovarian cancer. Gynecol. Oncol. 60, 238ā244.
Mostoufizadeh, M. and Scully, R. E. (1980) Malignant tumors arising in endometriosis. Clin. Obstet. Gynecol. 23, 951ā963.
Gucer, F., Pieber, D., and Arikan, M. G. (1998) Malignancy arising in extraovarian endometriosis during estrogen stimulation. Eur. J. Gynecol. Oncol. 19, 39ā41.
Jiang, X., Morland, S. J., Hitchcock, A., Thomas, E. J., and Campbell, I. G. (1998) Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage. Cancer Res. 58, 1707ā1712.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2000 Humana Press Inc.
About this protocol
Cite this protocol
Williams, A.R.W. (2000). Pathological Assessment of Ovarian Cancer. In: Bartlett, J.M.S. (eds) Ovarian Cancer. Methods in Molecular Medicineā¢, vol 39. Humana Press. https://doi.org/10.1385/1-59259-071-3:49
Download citation
DOI: https://doi.org/10.1385/1-59259-071-3:49
Publisher Name: Humana Press
Print ISBN: 978-0-89603-583-6
Online ISBN: 978-1-59259-071-1
eBook Packages: Springer Protocols